Medication info
DuoM 80/5 mg Tablet

DuoM 80/5 mg Tablet

Prescription medicationOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
McNulty Pharmaceuticals Co., Ltd.
Appearance
Biconvex oval double tablet in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201904301 · Approved 2019.06.21 · Insurance code 641502810

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
Child dose
○ Children: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
McNulty Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This drug is used in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using telmisartan or amlodipine. In such cases, this medication helps to control blood pressure more effectively. Maintaining consistent blood pressure control is crucial for preventing cardiovascular complications, thus improving the patient's health.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this drug may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administering this drug’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.

Child dose

○ Children: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus in pregnant women, particularly in the second and third trimesters, so pregnant women or those who may become pregnant should not take it. This medication should not be administered to individuals with allergies to the active ingredients or related components, nursing mothers, those with severe liver impairment or certain heart conditions, or individuals with hypotension or in shock. Patients with primary aldosteronism or certain heart valve diseases should use this medication cautiously, and those with impaired liver function should also take extra care. Patients with gastrointestinal disorders may experience issues such as gastrointestinal bleeding when taking this medication, so caution is advised. Patients with reduced kidney function, dialysis patients, and the elderly also require special caution when using this medication. Side effects such as dizziness and peripheral edema are common, and fainting or heart-related issues may occur rarely; thus, if any unusual symptoms appear, patients should consult medical personnel immediately. Symptoms of hypotension can manifest if blood pressure drops too low, particularly in patients who are deficient in fluid or salt, so their condition should be checked before taking the medication, and they must follow the doctor's instructions. During the treatment with this medication, potassium levels may rise; thus, caution is warranted if taken with potassium supplements or medications containing potassium, and regular blood tests are recommended. Patients at risk for myocardial infarction or angina should be cautious, as symptoms may worsen with the use of this medication. This medication may induce drowsiness or dizziness, so caution is advised when driving or operating hazardous machinery. There may be interactions with other medications, thus patients should consult medical personnel, especially if taking digoxin, lithium, warfarin, or non-steroidal anti-inflammatory drugs. This medication should not be taken during pregnancy, and if pregnancy is confirmed, it must be stopped immediately, and alternative treatments should be sought. It is also safer for nursing mothers to avoid this medication. The safety and efficacy of this medication in children or adolescents under 18 years have not been sufficiently established, and therefore its use is not recommended. In case of overdose, symptoms such as hypotension, heart rate changes, and dizziness may occur, requiring immediate medical attention for appropriate treatment. This medication must be kept out of reach of children and stored sealed until just before administration to maintain its quality.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste abnormalities
  • tremors
  • extrapyramidal disorders
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • increased liver enzymes
  • itching
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal impairment
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container that shields it from light, and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Biconvex oval double tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.